MyAverix Finance
US · Healthcare
Cannlabs Inc (CANL)
Drug Manufacturers - Specialty & Generic
Cannlabs Inc (CANL) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for CANL
Cannlabs Inc (CANL) — FAQ
What is CANL's P/E ratio?
The price-to-earnings (P/E) ratio for Cannlabs Inc (CANL) is 18.00 (data as of 2026-03-23).
Does Cannlabs Inc pay a dividend?
Dividend yield is not available in the current snapshot for Cannlabs Inc (CANL). Check the MyAverix Finance app for the latest dividend data.
What sector is Cannlabs Inc in?
Cannlabs Inc (CANL) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is CANL listed on?
CANL is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.